BeOne Medicines Announces Voluntary Agreement With U.S. Government To Expand Access To Innovative Cancer Medicines

ONC•2026-08-31

BeOne Medicines says agreement expands access to cancer medicines

BeOne Medicines AG said it has entered into a voluntary agreement with the U.S. government to expand access to innovative cancer medicines.

The company also recently announced a $300 million onshoring investment in New Jersey, bringing its total U.S. manufacturing investment to more than $1 billion.

BeOne Medicines Announces Voluntary Agreement With U.S. Government To Expand Access To Innovative Cancer Medicines

BeOne Medicines says agreement expands access to cancer medicines

Related News

CoStar sees Canada multifamily vacancy easing from H2 2027 as absorption tops deliveries

Teva, Trump administration pursue Medicaid drug pricing agreement under GENEROUS framework

Digi International expands senior secured revolving credit facility to $350 million

Estée Lauder EVP, General Counsel Rashida La Lande disposes of 14,357 common shares worth $1.51 million

Radiant Logistics names David Buss chief operating officer